HBIO
Price
$0.55
Change
+$0.05 (+10.00%)
Updated
Aug 26, 04:59 PM (EDT)
Capitalization
22.35M
72 days until earnings call
TELA
Price
$1.80
Change
-$0.03 (-1.64%)
Updated
Aug 26, 04:59 PM (EDT)
Capitalization
72.5M
71 days until earnings call
Interact to see
Advertisement

HBIO vs TELA

Header iconHBIO vs TELA Comparison
Open Charts HBIO vs TELABanner chart's image
Harvard Bioscience
Price$0.55
Change+$0.05 (+10.00%)
Volume$962
Capitalization22.35M
TELA Bio
Price$1.80
Change-$0.03 (-1.64%)
Volume$2.44K
Capitalization72.5M
HBIO vs TELA Comparison Chart in %
Loading...
HBIO
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
TELA
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
HBIO vs. TELA commentary
Aug 26, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is HBIO is a Hold and TELA is a Buy.

Interact to see
Advertisement
COMPARISON
Comparison
Aug 26, 2025
Stock price -- (HBIO: $0.50 vs. TELA: $1.83)
Brand notoriety: HBIO and TELA are both not notable
HBIO represents the Pharmaceuticals: Other, while TELA is part of the Medical/Nursing Services industry
Current volume relative to the 65-day Moving Average: HBIO: 52% vs. TELA: 107%
Market capitalization -- HBIO: $22.35M vs. TELA: $72.5M
HBIO [@Pharmaceuticals: Other] is valued at $22.35M. TELA’s [@Medical/Nursing Services] market capitalization is $72.5M. The market cap for tickers in the [@Pharmaceuticals: Other] industry ranges from $167.92B to $0. The market cap for tickers in the [@Medical/Nursing Services] industry ranges from $229.51B to $0. The average market capitalization across the [@Pharmaceuticals: Other] industry is $11.07B. The average market capitalization across the [@Medical/Nursing Services] industry is $5.67B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

HBIO’s FA Score shows that 1 FA rating(s) are green whileTELA’s FA Score has 0 green FA rating(s).

  • HBIO’s FA Score: 1 green, 4 red.
  • TELA’s FA Score: 0 green, 5 red.
According to our system of comparison, both HBIO and TELA are a bad buy in the long-term.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

HBIO’s TA Score shows that 4 TA indicator(s) are bullish while TELA’s TA Score has 4 bullish TA indicator(s).

  • HBIO’s TA Score: 4 bullish, 6 bearish.
  • TELA’s TA Score: 4 bullish, 5 bearish.
According to our system of comparison, TELA is a better buy in the short-term than HBIO.

Price Growth

HBIO (@Pharmaceuticals: Other) experienced а -0.53% price change this week, while TELA (@Medical/Nursing Services) price change was +7.65% for the same time period.

The average weekly price growth across all stocks in the @Pharmaceuticals: Other industry was +3.33%. For the same industry, the average monthly price growth was +2.01%, and the average quarterly price growth was +20.91%.

The average weekly price growth across all stocks in the @Medical/Nursing Services industry was +3.90%. For the same industry, the average monthly price growth was +3.07%, and the average quarterly price growth was +9.95%.

Reported Earning Dates

HBIO is expected to report earnings on Nov 06, 2025.

TELA is expected to report earnings on Nov 05, 2025.

Industries' Descriptions

@Pharmaceuticals: Other (+3.33% weekly)

Pharmaceuticals (Other) comprise companies that are involved in the discovery, development or manufacturing of therapeutic and preventative medicines. They often collaborate with or acquire other pharmaceutical/healthcare firms. Examples of companies in this segment include Bausch Health Companies Inc., Icon Plc and Perrigo Company Plc.

@Medical/Nursing Services (+3.90% weekly)

The medical/nursing services includes companies that provide medical-related services such as ambulance services, dialysis centers, respiratory therapy, blood testing and rehabilitation services. DaVita Inc., Chemed Corporation and Guardant Health, Inc. are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
TELA($72.5M) has a higher market cap than HBIO($22.4M). TELA YTD gains are higher at: -39.404 vs. HBIO (-76.209). TELA has higher annual earnings (EBITDA): -34.73M vs. HBIO (-46.8M). TELA has more cash in the bank: 35M vs. HBIO (7.44M). TELA (41.9M) and HBIO (43.3M) have identical debt. HBIO has higher revenues than TELA: HBIO (88.8M) vs TELA (75.3M).
HBIOTELAHBIO / TELA
Capitalization22.4M72.5M31%
EBITDA-46.8M-34.73M135%
Gain YTD-76.209-39.404193%
P/E RatioN/AN/A-
Revenue88.8M75.3M118%
Total Cash7.44M35M21%
Total Debt43.3M41.9M103%
FUNDAMENTALS RATINGS
HBIO: Fundamental Ratings
HBIO
OUTLOOK RATING
1..100
7
VALUATION
overvalued / fair valued / undervalued
1..100
100
Overvalued
PROFIT vs RISK RATING
1..100
100
SMR RATING
1..100
99
PRICE GROWTH RATING
1..100
64
P/E GROWTH RATING
1..100
2
SEASONALITY SCORE
1..100
90

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

TECHNICAL ANALYSIS
Technical Analysis
HBIOTELA
RSI
ODDS (%)
Bearish Trend 2 days ago
68%
N/A
Stochastic
ODDS (%)
Bullish Trend 2 days ago
81%
Bullish Trend 2 days ago
73%
Momentum
ODDS (%)
Bullish Trend 2 days ago
85%
Bearish Trend 2 days ago
86%
MACD
ODDS (%)
Bearish Trend 2 days ago
82%
Bullish Trend 2 days ago
64%
TrendWeek
ODDS (%)
Bearish Trend 2 days ago
84%
Bullish Trend 2 days ago
75%
TrendMonth
ODDS (%)
Bearish Trend 2 days ago
85%
Bearish Trend 2 days ago
84%
Advances
ODDS (%)
Bullish Trend 2 days ago
73%
Bullish Trend 2 days ago
75%
Declines
ODDS (%)
Bearish Trend 7 days ago
85%
Bearish Trend 14 days ago
84%
BollingerBands
ODDS (%)
Bearish Trend 5 days ago
67%
Bullish Trend 2 days ago
80%
Aroon
ODDS (%)
Bearish Trend 6 days ago
89%
Bearish Trend 2 days ago
84%
View a ticker or compare two or three
Interact to see
Advertisement
HBIO
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
TELA
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
LPIX1.250.34
+36.87%
Logipix International Corp.
TIAIY5.940.04
+0.70%
Telecom Italia S.p.A.
NTPIF4.21N/A
N/A
Nam Tai Property Inc.
NHKGF11.85N/A
N/A
NHK Spring Co., Ltd.
CTLPP60.75-0.10
-0.16%
Cantaloupe, Inc.